Paul C. Schorr III

All filings by Paul C. Schorr III on record concern NRC Health. We count 152 filings; the first trade dates from 11 January 2006 and the latest from 28 October 2013.

In open-market terms, that means 15 purchases worth €117k on one side and 93 sales worth €602k on the other. Netting one side against the other leaves €486k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 5 share grants and 16 option exercises. In 2013 alone, the filings show no purchases and 2 sales.

In size, the median ticket on the buying side is €6,626.

On 15 November 2013 came the latest disclosure, a transaction in NRC Health. The clock since the last published purchase (15 December 2010) now reads 5,807 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.